These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results From the TARGET BP I Randomized Clinical Trial. Kandzari DE; Weber MA; Pathak A; Zidar JP; Saxena M; David SW; Schmieder RE; Janas AJ; Langer C; Persu A; Mendelsohn FO; Ameloot K; Foster M; Fischell TA; Parise H; Mahfoud F Circulation; 2024 Jun; 149(24):1875-1884. PubMed ID: 38587557 [TBL] [Abstract][Full Text] [Related]
10. Ambulatory Blood Pressure Monitoring to Predict Response to Renal Denervation: A Post Hoc Analysis of the RADIANCE-HTN SOLO Study. Gosse P; Cremer A; Kirtane AJ; Lobo MD; Saxena M; Daemen J; Wang Y; Stegbauer J; Weber MA; Abraham J; Kario K; Bangalore S; Claude L; Liu Y; Azizi M Hypertension; 2021 Feb; 77(2):529-536. PubMed ID: 33356403 [TBL] [Abstract][Full Text] [Related]
11. Changes in blood pressure after crossover to ultrasound renal denervation in patients initially treated with sham in the RADIANCE-HTN SOLO trial. Mahfoud F; Bloch MJ; Azizi M; Wang Y; Schmieder RE; Lobo MD; Sharp ASP; Daemen J; Basile J; Weber MA; Scicli AP; McClure CK; Kirtane AJ EuroIntervention; 2021 Dec; 17(12):e1024-e1032. PubMed ID: 34236037 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of sympathetic mapping and ablation of renal nerves for the treatment of hypertension (SMART): 6-month follow-up of a randomised, controlled trial. Wang J; Yin Y; Lu C; Lu Z; Hu J; Wang Y; Ge J; Jiang H; Yao C; Yan X; Ma W; Qi X; Dang Y; Chen S; Zhu J; Wang D; Ding C; Wang W; Liu J; Wang Y; Li H; Pan Z; Cui K; Li C; Liang X; Chen W; Sobotka PA; Zhang J; Esler M; Sun N; Chen M; Huo Y EClinicalMedicine; 2024 Jun; 72():102626. PubMed ID: 38756107 [TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications. Kandzari DE; Townsend RR; Kario K; Mahfoud F; Weber MA; Schmieder RE; Pocock S; Tsioufis K; Konstantinidis D; Choi J; East C; Lauder L; Cohen DL; Kobayashi T; Schmid A; Lee DP; Ma A; Weil J; Agdirlioglu T; Schlaich MP; Shetty S; Devireddy CM; Lea J; Aoki J; Sharp ASP; Anderson R; Fahy M; DeBruin V; Brar S; Böhm M; J Am Coll Cardiol; 2023 Nov; 82(19):1809-1823. PubMed ID: 37914510 [TBL] [Abstract][Full Text] [Related]
14. Impact of Antihypertensive Medication Changes After Renal Denervation Among Different Patient Groups: SPYRAL HTN-ON MED. Townsend RR; Ferdinand KC; Kandzari DE; Kario K; Mahfoud F; Weber MA; Schmieder RE; Pocock S; Tsioufis K; David S; Steigerwalt S; Walton A; Hopper I; Bertolet B; Sharif F; Fengler K; Fahy M; Hettrick DA; Brar S; Böhm M Hypertension; 2024 May; 81(5):1095-1105. PubMed ID: 38314554 [TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial. Mahfoud F; Kandzari DE; Kario K; Townsend RR; Weber MA; Schmieder RE; Tsioufis K; Pocock S; Dimitriadis K; Choi JW; East C; D'Souza R; Sharp ASP; Ewen S; Walton A; Hopper I; Brar S; McKenna P; Fahy M; Böhm M Lancet; 2022 Apr; 399(10333):1401-1410. PubMed ID: 35390320 [TBL] [Abstract][Full Text] [Related]